Products for Research Use Only
RegisterLogin

DHODH-IN-32

CAT: 0804-HY-178941Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-178941Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
DHODH-IN-32 (Compound A1) is a DHODH inhibitor. DHODH-IN-32 shows significant cytotoxicity against NCI-60 cell lines, especially being sensitive to breast cancer, prostate cancer and leukemia cell lines. DHODH-IN-32 can induce cell apoptosis by activating the Caspase pathway. DHODH-IN-32 causes G0/G1 phase cell cycle arrest and inhibits cellular metabolism by ROS. DHODH-IN-32 exhibits significant anti-tumor properties in mouse breast cancer models. DHODH-IN-32 can be used for the study of breast cancer[1].
UNSPSC
12352101
Target
Apoptosis; Caspase; Dihydroorotate Dehydrogenase; Reactive Oxygen Species (ROS)
Related Pathways
Apoptosis; Immunology/Inflammation; Metabolic Enzyme/Protease; NF-κB
Applications
Cancer-programmed cell death
Field of Research
Cancer
Smiles
O=C(C[Se]C#N)NC1=CC(C(F)(F)F)=CC=C1
Molecular Formula
C10H7F3N2OSe
Molecular Weight
307.13
References & Citations
[1]Morán-Serradilla C, et al. Synthesis and characterization of novel phenyl carboxamide-selenium analogs: Identification of a potent DHODH inhibitor as a potential anticancer agent. Eur J Med Chem. 2026 Jan 5;301:118193.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Caspase 3; Caspase 7

Related Products

CatalogName
HY-135662DHODH-IN-34
HY-179531DHODH-IN-33
HY-135618DHODH-IN-3
HY-135676DHODH-IN-12
HY-163158DHODH-IN-24
HY-128068-01DHODH-IN-17
HY-163328DHODH-IN-25
HY-158023DHODH-IN-26
HY-149030DHODH-IN-21
HY-135619DHODH-IN-4

Alternative Products

CatalogName
GTR19274423-01DHODH-IN-32
560330-01DHODH
BA3997-5.1DHODH-IN-16
BA7297-50DHODH-IN-23
BA7296-5DHODH-IN-17
GWB-E42363DHODH Antibody
T211423-01DHODH-IN-29
T11024-01DHODH-IN-15
T63880-01DHODH-IN-22
388294DHODH discontinued

Popular Products